J J van Dongen

Author PubWeight™ 141.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997 3.80
2 Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 2000 3.70
3 The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in mice. Proc Natl Acad Sci U S A 1987 2.91
4 Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol 2001 2.71
5 Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med 1993 2.23
6 E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell 2000 1.99
7 T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med (Berl) 2001 1.86
8 Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia 1999 1.83
9 Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 1998 1.68
10 Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000 1.66
11 Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. J Exp Med 1988 1.62
12 Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques. Leukemia 1999 1.61
13 Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells. Blood 2001 1.59
14 Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999 1.55
15 Unique selection determinant in polyclonal V delta 2-J delta 1 junctional regions of human peripheral gamma delta T lymphocytes. J Immunol 1994 1.54
16 Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood 2001 1.52
17 [Immunology in medical practice. XXXV. Screening of suspected immunodeficiency: diagnostic protocols for patients with opportunistic or recurrent severe infections, wasting and failure to thrive]. Ned Tijdschr Geneeskd 2000 1.50
18 [Widely divergent clinical phenotype of x-linked agammaglobulinemia in two cousins]. Ned Tijdschr Geneeskd 2004 1.44
19 Minimal residual disease in leukaemia patients. Lancet Oncol 2001 1.43
20 Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole. J Pediatr 1989 1.39
21 Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells. J Immunol 1997 1.36
22 Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997 1.33
23 Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994 1.28
24 Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia 2001 1.28
25 Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Virology 1989 1.26
26 Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. Am J Pathol 1990 1.26
27 BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukemia 2000 1.24
28 TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood 1999 1.22
29 The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol 1993 1.21
30 Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000 1.14
31 Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia 2000 1.13
32 The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol 1991 1.12
33 Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. J Immunol 1985 1.11
34 Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev 1998 1.09
35 Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors. EMBO J 1999 1.09
36 The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation. Eur J Immunol 1992 1.07
37 Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol 1998 1.07
38 Reviewing Omenn syndrome. Eur J Pediatr 2001 1.07
39 T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level. J Immunol 1987 1.06
40 Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 2000 1.05
41 Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol 1999 1.05
42 Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia 1991 1.03
43 BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation. Leukemia 2001 1.02
44 Genetic variation in ICF syndrome: evidence for genetic heterogeneity. Hum Mutat 2000 1.01
45 Oligoclonal gammopathy in phenotypic diarrhea. J Pediatr Gastroenterol Nutr 2000 1.01
46 Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease. Chest 1989 0.98
47 Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood 2001 0.98
48 Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion. J Immunol 1997 0.97
49 Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood 1999 0.97
50 T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring. Leukemia 2000 0.97
51 Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. Blood 1993 0.95
52 Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease. Br J Haematol 2000 0.95
53 Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. Am J Hum Genet 1998 0.94
54 Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma. Blood 2000 0.94
55 BMA031, a monoclonal antibody suited to identify the T-cell receptor alpha beta/CD3 complex on viable human T lymphocytes in normal and disease states. Hum Immunol 1990 0.94
56 Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia. Leukemia 2001 0.93
57 Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 1987 0.93
58 Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 1990 0.93
59 N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements. Blood 2000 0.92
60 Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia 1997 0.92
61 Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. Blood 2001 0.92
62 Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. Blood 1984 0.92
63 Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis. Leukemia 1999 0.91
64 Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. Leukemia 1991 0.91
65 Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL. Leukemia 1988 0.91
66 tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. Leukemia 1993 0.90
67 Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia 1995 0.90
68 Immunophenotypic and immunogenotypic characteristics of TCRgammadelta+ T cell acute lymphoblastic leukemia. Leukemia 1999 0.89
69 Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set. Leukemia 1999 0.88
70 Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis. Leukemia 1994 0.88
71 Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Leukemia 1998 0.88
72 Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia 1993 0.87
73 Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia 1996 0.87
74 Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens. J Immunol 1986 0.87
75 Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Res 1987 0.87
76 Corticosteroids and the humoral immune response of mice i. Differential effect of corticosteroids upon antibody formation to sheep red blood cells in spleen and bone marrow. Cell Immunol 1978 0.87
77 Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature. Leukemia 1991 0.84
78 Bilateral exudative pleuritis, an unusual pulmonary onset of mixed connective tissue disease. Respiration 1985 0.84
79 Neonatal blood lymphocyte subpopulations: a different perspective when using absolute counts. Biol Neonate 2000 0.84
80 T-lymphoblastic lymphoma terminating as malignant histiocytosis with rearrangement of immunoglobulin heavy chain gene. Leukemia 1991 0.83
81 Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes. Neth J Med 1988 0.83
82 Confirmation of the assignment of the gene coding for the BA-2 antigen to human chromosome 12. Hum Genet 1984 0.83
83 Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase, a bacterial cell wall-degrading enzyme. Blood 1997 0.83
84 Characterization of the blast cells in acute leukemia with translocation (4;11): report of eight additional cases and of one case with a variant translocation. Leukemia 1987 0.82
85 Immunological marker analysis of mitogen-induced proliferating lymphocytes using BrdU incorporation or screening of metaphases. Staphylococcal protein A is a potent mitogen for CD4+ lymphocytes. Scand J Immunol 1990 0.81
86 Correction for erythroid cell contamination in microassay for immunophenotyping of neonatal lymphocytes. Arch Dis Child Fetal Neonatal Ed 1999 0.81
87 Easy detection of all T cell receptor gamma (TCRG) gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 1999 0.81
88 Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 1993 0.81
89 Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease? Pediatr Res 2000 0.81
90 Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia. Blood 1991 0.81
91 Analysis of immunoglobulin genes and T cell receptor genes as a diagnostic tool for the detection of lymphoid malignancies. Neth J Med 1987 0.81
92 Local treatment of renal allografts, a promising way to reduce the dosage of immunosuppressive drugs. Comparison of various ways of administering prednisolone. Transplantation 1986 0.80
93 Granulomatous slack skin. Report of three patients with an updated review of the literature. Dermatology 1998 0.80
94 Antigen receptors on T and B lymphocytes: parallels in organization and function. Immunol Rev 1993 0.80
95 Rearrangements of the human TCRD-deleting elements. Immunogenetics 1994 0.80
96 Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. Blood 2000 0.80
97 [Immunology in medical practice. XXXIV. Screening for suspected immunodeficiency: Introduction]. Ned Tijdschr Geneeskd 2000 0.80
98 Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993 0.80
99 Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia. Br J Haematol 2001 0.80
100 A DNA binding protein in human thymocytes recognizes the T cell receptor-delta-deleting element psi J alpha. J Immunol 1996 0.80
101 Transplantable human prostatic carcinoma (PC-82) in athymic nude mice: I. Hormone dependence and the concentration of androgens in plasma and tumor tissue. Prostate 1987 0.79
102 Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy. Leukemia 2000 0.79
103 T-cell receptor V delta-J alpha rearrangements in human thymocytes: the role of V delta-J alpha rearrangements in T-cell receptor-delta gene deletion. Immunology 1998 0.79
104 Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma. Leukemia 1989 0.79
105 The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders. J Clin Pathol 2001 0.79
106 Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias. Curr Top Microbiol Immunol 1999 0.79
107 Sequential metabolic characteristics following portacaval shunt in rats. Eur Surg Res 1986 0.79
108 Double marker analysis for terminal deoxynucleotidyl transferase and myeloid antigens in acute nonlymphocytic leukemia patients and healthy subjects. Haematol Blood Transfus 1990 0.79
109 Receptor diversity of human T-cell receptor gamma delta expressing cells. Prog Histochem Cytochem 1992 0.79
110 Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers. Leukemia 1993 0.79
111 Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vbeta antibodies. Leukemia 1998 0.79
112 Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. Leukemia 1991 0.78
113 Alternative splicing restricts translation of rearrangements at the T-cell receptor delta/alpha locus. Blood 1995 0.78
114 High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype. Leukemia 1993 0.78
115 Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review. Leukemia 1993 0.78
116 Flow cytometric immunophenotyping in the diagnosis and follow-up of immunodeficient children. Eur J Pediatr 2001 0.78
117 The 78C --> T (T254M) XHIM mutation: lack of a tight phenotype-genotype relationship. Blood 1999 0.78
118 Expression of the myeloid differentiation antigen CD33 depends on the presence of human chromosome 19 in human-mouse hybrids. Ann Hum Genet 1990 0.78
119 Immunophenotypical detection of minimal residual disease in acute leukemia. Crit Rev Oncol Hematol 1999 0.77
120 T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies. Leukemia 2001 0.77
121 PJA-BP expression and TCR delta deletion during human T cell differentiation. Int Immunol 1998 0.77
122 Familial disseminated atypical mycobacterial infection in childhood. Lancet 1995 0.77
123 Oligoclonal T cell proliferative disorder in combined immunodeficiency. Pediatr Res 1988 0.77
124 Longitudinal follow-up of blood lymphocyte subpopulations from birth to 1 year of age. J Pediatr 1998 0.77
125 A combined immunodeficiency with oligoclonal CD8+, V beta 3-expressing, cytotoxic T lymphocytes in the peripheral blood. J Immunol 1992 0.77
126 High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood 1992 0.76
127 Limited combinatorial repertoire of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias. Leukemia 1991 0.76
128 Detection of residual disease in acute leukemia using immunological markers. Cancer Treat Res 1988 0.76
129 Southern blot detection of immunoglobulin lambda light chain gene rearrangements for clonality studies. Leukemia 1995 0.76
130 Identification of immunoglobulin lambda isotype gene rearrangements by Southern blot analysis. Leukemia 1996 0.76
131 Repertoire selection of human gamma delta T cells. Res Immunol 1990 0.75
132 De novo deletion (2) (p11.2p13): clinical, cytogenetic, and immunological data. J Med Genet 1994 0.75
133 Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer 1998 0.75
134 Lymphoma with multi-gene rearrangement on the level of immunoglobulin heavy chain, light chain, and T-cell receptor beta chain. Am J Hematol 1998 0.75
135 Immunological characterisation of cells in cerebrospinal fluid from patients with lymphoid malignancies. Lancet 1984 0.75
136 Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. Blood 1998 0.75
137 Expression of mdr1 and mdr3 multidrug-resistance genes in hairy cell leukaemia. Eur J Cancer 1991 0.75
138 Phenotypic and genotypic characteristics of human early T-cell differentiation: the T-cell acute lymphoblastic leukaemia model. Res Immunol 1994 0.75
139 Four aged siblings with B cell chronic lymphocytic leukemia. Leukemia 1997 0.75
140 Polyclonal expansion of T-cell receptor-gamma delta+ T lymphocytes associated with neutropenia and thrombocytopenia. Leukemia 1992 0.75
141 [Terminal deoxynucleotidyltransferase (TdT)-positive cells in cerebrospinal fluid of children with leukemia or non-Hodgkin lymphoma: implications for the diagnosis of central nervous system leukemia]. Tijdschr Kindergeneeskd 1986 0.75
142 The small subpopulation of T cell marker+/TdT+ cells in the human bone marrow may represent prothymocytes. Adv Exp Med Biol 1985 0.75
143 Bronchoalveolar lavage in extrapulmonary sarcoidosis. Chest 1988 0.75
144 Small-cell undifferentiated (neuroendocrine) carcinoma of the cecum in a child with common variable immunodeficiency. Am J Pediatr Hematol Oncol 1993 0.75
145 The presence of somatic mutations in immunoglobulin genes of B cell acute lymphoblastic leukemia (ALL-L3) supports assignment as Burkitt's leukemia-lymphoma rather than B-lineage ALL. Leukemia 2001 0.75
146 [Pneumocystis carinii pneumonia in patients with a severe combined immunodeficiency]. Ned Tijdschr Geneeskd 1991 0.75
147 Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells. Oncogene 1994 0.75
148 Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis. Leukemia 1993 0.75
149 Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. Leukemia 1992 0.75
150 Contribution of electron microscopy to the classification of minimally differentiated acute leukemias in children. Recent Results Cancer Res 1993 0.75
151 Clearance of maternal leukaemic cells in a neonate. Br J Haematol 2001 0.75
152 Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease. Leukemia 1990 0.75
153 Staging of Sezary syndrome with somatostatin receptor scintigraphy. Br J Dermatol 1996 0.75
154 Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Onkologie 1990 0.75
155 Low frequency of reverse transcription polymerase chain reaction-detectable chromosome aberrations in relapsed acute myeloid leukaemia: implications for detection of minimal residual disease. Br J Haematol 2001 0.75
156 Analysing the developing lymphocyte system of neonates and infants. Eur J Pediatr 1999 0.75
157 Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma. Blood 1989 0.75
158 [The Nobel Prize for medicine 1987]. Ned Tijdschr Geneeskd 1987 0.75
159 [Immunoglobulin genes and T-cell receptor genes and the expression of immunological markers. II. Immunological diagnosis of malignant lymphatic diseases]. Ned Tijdschr Geneeskd 1988 0.75
160 [Detection of low numbers of malignant cells in patients with leukemia or non-Hodgkin lymphoma: use of immunological markers]. Tijdschr Kindergeneeskd 1986 0.75
161 Alveolitis in an asymptomatic pigeon breeder. Chest 1985 0.75
162 Pulmonary alveolar proteinosis: determination of prostaglandins and leukotrienes in lavage fluid. Lung 1987 0.75
163 [Icterus of the newborn infant: a stubborn problem]. Ned Tijdschr Geneeskd 1984 0.75
164 Expression of the human immunoglobulin heavy chain gene of the 14q+ chromosome in a t(8;14)-positive Burkitt lymphoma cell line demonstrated in somatic cell hybrids. Cancer Genet Cytogenet 1986 0.75
165 [Immunoglobulin genes and T-cell receptor genes and the expression of immunological markers. I. The construction of the specific immune system]. Ned Tijdschr Geneeskd 1988 0.75
166 Simultaneous occurrence of acute monoblastic leukemia and an abnormal B-cell clone with both cell types characterized by specific cytogenetic and immunological markers. Scand J Haematol 1986 0.75
167 TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics. Br J Haematol 1988 0.75
168 Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells. Cancer Treat Res 1988 0.75
169 Immunoglobulin lambda isotype gene rearrangements in B cell malignancies. Leukemia 2001 0.75
170 Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis. Leukemia 1993 0.75
171 Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy. Med Pediatr Oncol 2001 0.75